Neumora Therapeutics is trading 12.78% up at $0.40 after-hours, with no clear company-specific catalyst identified.

  • The stock closed the October 14 regular session at $0.35.
  • Its regular-session decline was reported amid hotter-than-expected inflation, which pushed Treasury yields higher and weighed on equities.
  • That broader market pressure does not explain the opposite-direction after-hours move, whose reason remains unclear.